Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551820 · ClinicalTrials.gov registry record
Study of Peri-operative and Acute Outcomes After Robotic-assisted Cholecystectomy
A clinical trial, sponsored by Intuitive Surgical.
- Completed
- Registry status
- 520
- Enrollment target
NCT04551820: Completed study, sponsored by Intuitive Surgical.
NCT04551820 is a clinical trial that has completed, run by Intuitive Surgical. The registered enrollment target is 520 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04551820 has completed, sponsored by Intuitive Surgical.
- COMPLETED
- Registry status
- 520 participants
- Enrollment target
Study Summary
A multi-center retrospective chart review of short-term outcomes associated with robotic-assisted cholecystectomies performed during regular hours and after-hours.
Primary Outcome
The rate of conversion of the cholecystectomy to open, defined as robotic-assisted surgery converted to an open approach.
Interventions
- PROCEDURE Regular Hours
- PROCEDURE After Hours
- DEVICE Robotic-assisted Cholecystectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2020-08-05 |
| Est. Completion | 2021-09-30 |
What the finished NCT04551820 record still lists
NCT04551820 is an observational study that tracks outcomes without assigning an intervention. The registered 520 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Regular Hours is the first listed.
NCT04551820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04551820 about?
NCT04551820 is a clinical study titled "Study of Peri-operative and Acute Outcomes After Robotic-assisted Cholecystectomy". A multi-center retrospective chart review of short-term outcomes associated with robotic-assisted cholecystectomies performed during regular hours and after-hours.
What is the current status of trial NCT04551820?
This trial is currently completed. The enrollment target is 520 participants. The study started on 2020-08-05. Estimated completion is 2021-09-30.
What interventions are being tested in trial NCT04551820?
The interventions under investigation include: Regular Hours (PROCEDURE), After Hours (PROCEDURE), Robotic-assisted Cholecystectomy (DEVICE).
Who is sponsoring clinical trial NCT04551820?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
- NCT05445778 · 520 participants · Phase 3
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
- NCT05498428 · 520 participants · Phase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI